Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy

NCT01726205 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2012-11-14

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of pregabalin or pregabalin and continuous wound infusion versus placebo for analgesia following thoracotomy

Conditions

  • Post-thoracotomy Pain

Interventions

DRUG

Pregabalin and normal saline infusion, PRG

DRUG

Pregabalin and ropivacaine 02% infusion

DRUG

Placebo drug, normal saline infusion

Sponsors & Collaborators

  • Attikon Hospital

    lead OTHER

Principal Investigators

  • Tatiana Sidiropoulou · Attikon Hospital

  • Eyaggelos Giavasopoulos · Attikon Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01726205 on ClinicalTrials.gov